Skip to main content
. 2018;19(1):161–166. doi: 10.22034/APJCP.2018.19.1.161

Table 1.

Profile Molecular Subtypes of Indonesian Breast Carcinoma Based on Five Molecular Markers and Their Clinical Factors Characteristics (N = 247 Cases)

Variable All cases Luminal A Luminal B HER2+. Triple-Negative p- value
n (%) n (%) n (%) n (%) n (%)
247 (100) 102 (41.3) 34 (13.8) 48 (19.4) 63 (25.5)
Age at diagnosis
mean ± SD (years) 51.89 ± 11.44 52.35 ± 11.63 49.70 ± 11.25 52.52 ± 10.13 51.84 ± 12.26
Median (min-max years) 52.00 (24-92) 50.00 (24-92) 49.50 (26-72) 53.00 (31-77) 52.00 (27-81)
Age group 0.080
 < 40 years old 32 (13.0) 8 (7.8) 8 (23.5) 6 (12.5) 10 (15.9)
 40 - 50 years old 83 (33.6) 43 (42.2) 10 (29.4) 11 (22.9) 19 (30.1)
 > 50 years old 132 (53.4) 51 (50.0) 16 (47.1) 31 (64.6) 34 (54.0)
Tumor size group 5.34±3.98 5.01 ± 3.71 4.89 ± 3.30 5.31 ± 4.08 6.13 ± 4.60
mean ± SD (cm)
Median (min-max) cm 4.00 (0.5-21) 4.00 (1-21) 4.50 (1-12) 4.25 (0.6-17) 5.00 (0.5-20)
Tumor size group 0.462
 < 2 cm 42 (17.0) 16 (15.7) 9 (26.5) 10 (20.8) 7 (11.1)
 2– 5 cm 110 (44.5) 50 (49.0) 12 (35.3) 20 (41.7) 28 (44.4)
 > 5 cm 95 (38.5) 36 (35.3) 13 (38.2) 18 (37.5) 28 (44.4)